Position in GRAL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,067,420
+$502,395 QoQ
Shares Held
30,283
0.0% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#79
of 373 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $33,829,409 across 15 Diagnostics & Research names. GRAL ranks #6 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
16,090 | $8,066,882 | |
| 2 | LH |
Labcorp Holdings Inc.
|
27,447 | $7,685,160 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
2,500 | $3,193,775 | |
| 4 | DHR |
Danaher Corp /De/
|
16,250 | $3,095,300 | |
| 5 | WAT |
Waters Corp /De/
|
7,877 | $2,954,190 | |
| 6 | GRAL |
GRAIL, Inc.
This page
|
30,283 | $2,067,420 | |
| 7 | A |
Agilent Technologies, Inc.
|
13,309 | $1,767,834 | |
| 8 | NEO |
Neogenomics Inc
|
109,500 | $1,597,605 |
All Filings in GRAL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,067,420 | 30,283 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,565,025 | 30,283 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,708,923 | 31,650 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,038,388 | 34,473 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,783,708 | 34,689 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $799,657 | 31,310 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $558,883 | 31,310 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $531,039 | 38,593 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $415,543 | 27,036 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||